Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Calcium Channel Antagonists [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
AMLODIPINE 64,924 10,161 15.7% 26,787 5,585 62.8 yrs 57.0%
DILTIAZEM 14,726 4,562 31.0% 6,674 1,762 67.1 yrs 70.8%
VERAPAMIL 9,320 2,630 28.2% 3,576 1,080 58.2 yrs 62.9%
NIFEDIPINE 8,266 1,081 13.1% 2,637 539 54.2 yrs 66.5%
NICARDIPINE 2,317 182 7.9% 1,073 294 56.7 yrs 60.8%
FELODIPINE 1,476 94 6.4% 559 204 64.3 yrs 60.6%
NIMODIPINE 416 32 7.7% 158 62 53.9 yrs 62.3%
CLEVIDIPINE 201 5 2.5% 20 6 61.9 yrs 32.7%
ISRADIPINE 119 14 11.8% 72 9 55.5 yrs 46.3%
NISOLDIPINE 52 5 9.6% 7 1 68.4 yrs 51.0%

Head-to-Head Comparisons

AMLODIPINE vs DILTIAZEM AMLODIPINE vs VERAPAMIL AMLODIPINE vs NIFEDIPINE AMLODIPINE vs NICARDIPINE DILTIAZEM vs VERAPAMIL DILTIAZEM vs NIFEDIPINE DILTIAZEM vs NICARDIPINE VERAPAMIL vs NIFEDIPINE VERAPAMIL vs NICARDIPINE NIFEDIPINE vs NICARDIPINE
← Back to Calcium Channel Antagonists [MoA] Class side effects →